MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-018-33019-4

Медицинская библиотека · Scientific reports · 2018

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.

Nath Kavindra, Roman Jeffrey, Nelson David S, Guo Lili, Lee Seung-Cheol, Orlovskiy Stepan, Muriuki Kevin, Heitjan Daniel F, Pickup Stephen, Leeper Dennis B, Blair Ian A, Putt Mary E, Glickson Jerry D

Сравнительное исследованиеСтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Lonidamine (LND), a metabolic modulator, sensitizes DB-1 human melanoma to doxorubicin (DOX) chemotherapy by acidifying and de-energizing the tumor. This report compares the effects of LND on two human melanoma lines, DB-1 and WM983B, which exhibit different metabolic properties. Using liquid chromatography mass spectrometry and Seahorse analysis, we show that DB-1 was more glycolytic than WM983B in vitro. 31P magnetic resonance spectroscopy (MRS) indicates that LND (100 mg/kg, i.p.) induces similar selective acidification and de-energization of WM983B xenografts in immunosuppressed mice. Over three hours, intracellular pH (pHi) of WM983B decreased from 6.91 ± 0.03 to 6.59 ± 0.10 (p = 0.03), whereas extracellular pH (pHe) of this tumor changed from 7.03 ± 0.05 to 6.89 ± 0.06 (p = 0.19). A decline in bioenergetics (β-NTP/Pi) of 55 ± 5.0% (p = 0.03) accompanied the decline in pHi of WM983B. Using 1H MRS with a selective multiquantum pulse sequence and Hadamard localization, we show that LND induced a significant increase in tumor lactate levels (p < 0.01). LND pre-treatment followed by DOX (10 mg/kg, i.v.) produced a growth delay of 13.7 days in WM983B (p < 0.01 versus control), a growth delay significantly smaller than the 25.4 days that occurred with DB-1 (p = 0.03 versus WM983B). Differences in relative levels of glycolysis may produce differential therapeutic responses of DB-1 and WM983B melanomas.

Для цитирования: Nath Kavindra, Roman Jeffrey, Nelson David S, Guo Lili, Lee Seung-Cheol, Orlovskiy Stepan, Muriuki Kevin, Heitjan Daniel F, Pickup Stephen, Leeper Dennis B, Blair Ian A, Putt Mary E, Glickson Jerry D. Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.. Scientific reports. 2018. DOI: 10.1038/s41598-018-33019-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.